Login
Home
Charts
Search
Watchlist
Products

Kabra Drugs Ltd

KABRADG·BSE
₹19.20+3.17%Wed, 23 Sept '26 15:29
Industry:Trading
Indices:

Kabra Drugs Ltd

KABRADG
BSE
₹19.20
+3.17%
|Wed, 23 Sept '26 15:29
SOICxStockScans Reports
Industry
Trading
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹46Cr
Close
Close Price
₹19.20
Industry
Industry
Trading
PE
Price To Earnings
6.00
PS
Price To Sales
0.35
Revenue
Revenue
₹132Cr
Rev Gr TTM
Revenue Growth TTM
1,743.50%
PAT Gr TTM
PAT Growth TTM
822.86%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
0000000720303546
Growth YoY
Revenue Growth YoY%
546.4
Expenses
ExpensesCr
0001010818283443
Operating Profit
Operating ProfitCr
000-10-10-12213
OPM
OPM%
-7.310.38.03.86.0
Other Income
Other IncomeCr
000000100000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000-10-10-12313
Tax
TaxCr
000000000001
PAT
PATCr
000-10-10-12312
Growth YoY
PAT Growth YoY%
-116.7-83.3-164.3-358.3-207.7-390.9205.49.1560.0575.9171.8524.0
NPM
NPM%
-7.09.38.43.04.6
EPS
EPS₹
-0.3-0.3-0.8-1.2-0.4-0.50.2-0.20.81.10.50.9
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
0000000720303546
Growth YoY
Revenue Growth YoY%
546.4
Expenses
ExpensesCr
0001010818283443
Operating Profit
Operating ProfitCr
000-10-10-12213
OPM
OPM%
-7.310.38.03.86.0
Other Income
Other IncomeCr
000000100000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000-10-10-12313
Tax
TaxCr
000000000001
PAT
PATCr
000-10-10-12312
Growth YoY
PAT Growth YoY%
-116.7-83.3-164.3-358.3-207.7-390.9205.49.1560.0575.9171.8524.0
NPM
NPM%
-7.09.38.43.04.6
EPS
EPS₹
-0.3-0.3-0.8-1.2-0.4-0.50.2-0.20.81.10.50.9

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1082000000093132
Growth
Revenue Growth%
16.9-21.2-76.3-100.01,743.5
Expenses
ExpensesCr
973000001287123
Operating Profit
Operating ProfitCr
00-100000-1-259
OPM
OPM%
4.75.8-57.35.86.5
Other Income
Other IncomeCr
00-1000000101
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
00-200000-1-169
Tax
TaxCr
000000000011
PAT
PATCr
00-200000-1-158
Growth
PAT Growth%
-61.1374.4-1,910.093.063.8-202.1-3.0-82.3-117.8-47.5556.9822.9
NPM
NPM%
0.31.7-130.75.35.8
EPS
EPS₹
0.10.3-5.4-0.4-0.1-0.4-0.4-0.8-1.7-1.02.13.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1082000000093132
Growth
Revenue Growth%
16.9-21.2-76.3-100.01,743.5
Expenses
ExpensesCr
973000001287123
Operating Profit
Operating ProfitCr
00-100000-1-259
OPM
OPM%
4.75.8-57.35.86.5
Other Income
Other IncomeCr
00-1000000101
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
00-200000-1-169
Tax
TaxCr
000000000011
PAT
PATCr
00-200000-1-158
Growth
PAT Growth%
-61.1374.4-1,910.093.063.8-202.1-3.0-82.3-117.8-47.5556.9822.9
NPM
NPM%
0.31.7-130.75.35.8
EPS
EPS₹
0.10.3-5.4-0.4-0.1-0.4-0.4-0.8-1.7-1.02.13.2

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
4444444442424
Reserves
ReservesCr
-2-2-4-4-4-5-5-5-616
Current Liabilities
Current LiabilitiesCr
431112113157
Non Current Liabilities
Non Current LiabilitiesCr
21000000000
Total Liabilities
Total LiabilitiesCr
9621111152586
Current Assets
Current AssetsCr
6411111152584
Non Current Assets
Non Current AssetsCr
33000000012
Total Assets
Total AssetsCr
9621111152586
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
4444444442424
Reserves
ReservesCr
-2-2-4-4-4-5-5-5-616
Current Liabilities
Current LiabilitiesCr
431112113157
Non Current Liabilities
Non Current LiabilitiesCr
21000000000
Total Liabilities
Total LiabilitiesCr
9621111152586
Current Assets
Current AssetsCr
6411111152584
Non Current Assets
Non Current AssetsCr
33000000012
Total Assets
Total AssetsCr
9621111152586

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
000000000-5-9
Investing Cash Flow
Investing Cash FlowCr
0020000000-1
Financing Cash Flow
Financing Cash FlowCr
00-1000003230
Net Cash Flow
Net Cash FlowCr
00000000319-11
Free Cash Flow
Free Cash FlowCr
001000000-5-10
CFO To PAT
CFO To PAT%
1,030.2237.44.9107.877.3138.472.2104.928.3433.6-190.8
CFO To EBITDA
CFO To EBITDA%
62.070.211.2129.392.3167.576.3103.028.3274.0-177.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
000000000-5-9
Investing Cash Flow
Investing Cash FlowCr
0020000000-1
Financing Cash Flow
Financing Cash FlowCr
00-1000003230
Net Cash Flow
Net Cash FlowCr
00000000319-11
Free Cash Flow
Free Cash FlowCr
001000000-5-10
CFO To PAT
CFO To PAT%
1,030.2237.44.9107.877.3138.472.2104.928.3433.6-190.8
CFO To EBITDA
CFO To EBITDA%
62.070.211.2129.392.3167.576.3103.028.3274.0-177.5

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
43101223265846
Price To Earnings
Price To Earnings
148.821.511.86.0
Price To Sales
Price To Sales
0.40.40.80.60.3
Price To Book
Price To Book
1.51.17.08.0-52.3-5.1-3.3-2.11.12.01.5
EV To EBITDA
EV To EBITDA
13.510.1-1.9-6.6-40.5-17.2-11.1-3.0-3.19.14.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
18.933.222.59.89.8
OPM
OPM%
4.75.8-57.35.86.5
NPM
NPM%
0.31.7-130.75.35.8
ROCE
ROCE%
4.67.2-244.8-22.7-9.4-26.0-29.3-51.9-304.9-4.319.119.1
ROE
ROE%
1.05.1-1,198.6-516.9215.086.747.246.250.2-4.416.816.8
ROA
ROA%
0.32.0-138.9-11.1-4.2-12.8-25.4-48.0-16.1-4.35.85.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
43101223265846
Price To Earnings
Price To Earnings
148.821.511.86.0
Price To Sales
Price To Sales
0.40.40.80.60.3
Price To Book
Price To Book
1.51.17.08.0-52.3-5.1-3.3-2.11.12.01.5
EV To EBITDA
EV To EBITDA
13.510.1-1.9-6.6-40.5-17.2-11.1-3.0-3.19.14.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
18.933.222.59.89.8
OPM
OPM%
4.75.8-57.35.86.5
NPM
NPM%
0.31.7-130.75.35.8
ROCE
ROCE%
4.67.2-244.8-22.7-9.4-26.0-29.3-51.9-304.9-4.319.119.1
ROE
ROE%
1.05.1-1,198.6-516.9215.086.747.246.250.2-4.416.816.8
ROA
ROA%
0.32.0-138.9-11.1-4.2-12.8-25.4-48.0-16.1-4.35.85.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Kabra Drugs Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/txxhlmp1u4cd4dog8ff3k4bn.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/r5wl65ftktklq8wv7y3zb07q.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/clup1cu8f3rby251aej3f0oo.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/r85ohesdj87t91r2zeh9cswa.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/3m6n26xm85ksmdgpt02qgyl5.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/7vksi3mbr0eprahrpkdq2m6u.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/cqjdljxxm8ifebgw1282xmpx.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/9ofoa4j0gh9b0h6ewj6hzjbb.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/zol4ms2bac205s9187slfjht.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/wyaovbji6iwh94newcdo3fqn.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/4co9c9m3umbtdxbt9rvkznk7.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/k0mh665dyv5v5qozv8kqgmr9.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/qdxujzpdz4nz3f5gw0smj4qv.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/bqn90wqpurq085r76jcofke5.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/81xn1uoi270eltqb0yqdybi3.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies